CAR T Cell Therapy (IMAGE)
Caption
Chimeric antigen receptor therapy. CAR molecules (light blue) bind to CD19 molecules on a cancer cell leading to segregation of granzyme vesicles (yellow) that activate apoptosis.
Credit
La Jolla Institute for Immunology
Usage Restrictions
Only in conjunction with articles describing this research.
License
Licensed content